Top Canadian Marijuana Stocks for TradersThe Canadian cannabis sector remains a focus for investors as September trading continues. Market leaders are working to expand operations while positioning for long-term growth. Meanwhile, the U.S. cannabis industry has surpassed $33 billion in annual sales, with forecasts expecting over $50 billion by 2030. These numbers highlight the global opportunity for Canadian companies with cross-border strategies. Recently, headlines reported new momentum in U.S. legalizati ...

行业政策动态 - 美国大麻合法化进程遭遇阻力 九名国会议员联合致信特朗普反对联邦层面大麻重新分类[1][3] - 反对派以保护青少年为由 指控重新分类将使大麻企业获得数十亿美元税收优惠并助长毒品卡特尔[3][4] - 政策不确定性导致行业情绪受挫 大麻股表现逊于大盘 其中Curaleaf股价单日下跌超2% 同期标普500指数仅下跌0.6%[1] 企业影响分析 - 多州运营商Curaleaf直接受到政策波动冲击 股价跌幅显著大于大盘指数[1] - 行业面临金融服务缺失等结构性挑战 联邦与州法律不一致继续制约行业发展[4] - 若重新分类提案被否决 大麻行业将维持当前各州法律拼凑式发展的碎片化格局[4] 政策推进前景 - 特朗普政府正考虑根据DEA分类标准对大麻进行重新分类 拟将其从最危险药物清单中移除[2] - 该提案获得广泛民众支持 但遭遇部分立法者强烈反对[3] - 反对派领袖德克萨斯州共和党议员Pete Sessions与反合法化组织SAM协同开展阻挠行动[3]